Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-04-10

Clinical Trial Update: Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality Study [Phase 4]

View source ↗

Summary

Phase 4 trial update on Alfuzosin XL for lower urinary tract symptoms due to prostatic disease has completed, with data on efficacy and sexual function outcomes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alfuzosin XL (alfuzosin)

Snippet

Sponsor: Sanofi | Conditions: Prostatic Diseases | Phase 4 | Status: COMPLETED